**CA4509131088 - Common Stock - After market: 2.69 -0.01 (-0.37%)**

We assign a fundamental rating of **3** out of 10 to **IAG**. **IAG** was compared to 969 industry peers in the **Metals & Mining** industry. Both the profitability and financial health of **IAG** have multiple concerns. While showing a medium growth rate, **IAG** is valued expensive at the moment.

*Note: IAG has only limited data available, so a full analysis was not possible, which makes the total rating unfair.*

The Piotroski-F score of **IAG** is **5.00**. This is a neutral score and indicates average health and profitability for **IAG**.

When comparing the current price to the book value of **IAG**, it is valued rather cheaply. It is trading at **0.61** times its book value.

Compared to an average industry price book ratio of 1.68, **IAG** is valued rather cheaply. On top of this, **IAG** is cheaper than **83%** of the companies listed in the same industry.

Compared to an average industry **Enterprise Value to EBITDA** ratio of 6.23, **IAG** is valued in line with its industry peers.

Besides the negative Price/Earnings Ratio, also the **Forward Price/Earnings Ratio** is negative for **IAG**. No positive earnings are expected for the next year.

Price/Book (0.61) VS Industry: 83% outperformed.

6,836.00

0.03

Enterprise Value/ EBITDA (4.77) VS Industry: 60% outperformed.

374.61

0.07

Looking at the last year, **IAG** shows a very strong growth in **Revenue**. The Revenue has grown by **127.61%**.

When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.

The **Revenue** has been decreasing by **-2.62%** on average over the past 5 years.

Based on estimates for the next 5 years, **IAG** will show a small growth in **Revenue**. The Revenue will grow by **0.99%** on average per year.

The earnings per share for **IAG** have decreased strongly by **-120.00%** in the last year.

Past | Future | ||||||
---|---|---|---|---|---|---|---|

5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |

EPS | N/A | N/A | -120% | -630.23% | 456.53% | 209.94% | N/A |

Revenue | -2.62% | -3.45% | 127.61% | -37.13% | -2.07% | 0.99% | N/A |

A Current Ratio of **2.35** indicates that **IAG** has no problem at all paying its short term obligations.

The Quick Ratio is in line with the industry averages, which is at **2.16**.

Based on the Altman-Z score of **0.94**, we must say that **IAG** is in the distress zone and has some risk of bankruptcy.

When comparing the Altman-Z score of **IAG** to the average industry Altman-Z score of **2.51**, **IAG** is less financially healthy than its industry peers.

Debt/Equity (0.46) VS Industry: 6% outperformed.

4.14

0.00

Quick Ratio (2.04) VS Industry: 48% outperformed.

0.00

178.59

Current Ratio (2.35) VS Industry: 46% outperformed.

0.00

178.59

Altman-Z (0.94) VS Industry: 38% outperformed.

-22,403.48

2,514.55

NYSE:IAG (3/29/2023, 7:12:58 PM)**-0.01 (-0.37%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryMetals & Mining

Earnings (Last)02-16 2023-02-16/amc

Earnings (Next)05-01 2023-05-01/amc

Inst Owners48.16%

Inst Owner Change-2.89%

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap1.29B

Analysts69.23

Price Target2.9 (7.41%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)N/A

DPN/A

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)-940.51%

Min EPS beat(2)-1880.2%

Max EPS beat(2)-0.82%

EPS beat(4)1

Avg EPS beat(4)-453.18%

Min EPS beat(4)-1880.2%

Max EPS beat(4)211.55%

Revenue beat(2)2

Avg Revenue beat(2)85.09%

Min Revenue beat(2)14.12%

Max Revenue beat(2)156.05%

Revenue beat(4)3

Avg Revenue beat(4)42.84%

Min Revenue beat(4)-4.49%

Max Revenue beat(4)156.05%

PT rev (1m)-4.28%

PT rev (3m)19.43%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-400%

EPS NY rev (1m)-483.06%

EPS NY rev (3m)-483.06%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-20.59%

Revenue NY rev (1m)-4.59%

Revenue NY rev (3m)-4.59%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | N/A | ||

P/S | 0.65 | ||

P/FCF | N/A | ||

P/OCF | 3.52 | ||

P/B | 0.61 | ||

P/tB | 0.61 | ||

EV/EBITDA | 4.77 |

EPS(TTM)-0.01

EYN/A

EPS(NY)-0.07

Fwd EYN/A

FCF(TTM)-0.79

FCFYN/A

OCF(TTM)0.77

OCFY28.45%

SpS4.16

BVpS4.45

TBVpS4.45

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | N/A | ||

ROE | N/A | ||

ROIC | 3.19% | ||

ROICexc | 3.58% | ||

ROICexgc | 3.58% | ||

OM | 7.66% | ||

PM | N/A | ||

GM | 15.46% |

ROICexgc(3y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5Y-2.37%

ROICexc(3y)N/A

ROICexc growth 3YN/A

ROICexc growth 5Y-2.37%

OM growth 3YN/A

OM growth 5Y3.01%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y33.16%

GM growth 5Y2.01%

F-Score5

Asset Turnover0.45

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.46 | ||

Debt/FCF | N/A | ||

Debt/EBITDA | 2.52 | ||

Cap/Depr | 307.69% | ||

Profit Quality | N/A | ||

Current Ratio | 2.35 | ||

Quick Ratio | 2.04 | ||

Altman-Z | 0.94 |

F-Score5

WACC9.55%

ROIC/WACC0.37

Cap/Depr(3y)198.53%

Cap/Depr(5y)160.43%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

Growth

EPS 1Y-120%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q-122.22%

EPS Next Y-630.23%

EPS Next 2Y456.53%

EPS Next 3Y209.94%

EPS Next 5YN/A

Revenue growth 1Y127.61%

Revenue growth 3Y-3.45%

Revenue growth 5Y-2.62%

Revenue growth Q2Q5110.87%

Revenue Next Year-37.13%

Revenue Next 2Y-2.07%

Revenue Next 3Y0.99%

Revenue Next 5YN/A

EBIT growth 1Y353.91%

EBIT growth 3YN/A

EBIT growth 5Y0.31%

EBIT Next Year349.75%

EBIT Next 3Y130.44%

EBIT Next 5YN/A

FCF growth 1Y-11.19%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y29.09%

OCF growth 3Y0.45%

OCF growth 5Y4.49%

*Find stocks with similar Fundamental rating on the USA*

*Find the competitors with the best fundamentals on the USA*

*Find the competitors with the best valuation on the USA*

*Find the competitors with the best dividend on the USA*